FDA approves Recarbrio for complicated UTI and intra-abdominal infections - Medical Economics

FDA approves Recarbrio for complicated UTI and intra-abdominal infections  Medical Economics

The FDA has announced the approval of Merck's combination drug Recarbrio (imipenem, cilastatin, and relebactam), indicated for the treatment of complicated ...



Comments

Popular posts from this blog

The Best Flea Treatments for Cats and Dogs

Everything You Need to Know About Mite and Flea Bites

Is Citronella Safe for Dogs? A Veterinarian Provides Guidance